Sets Revenue Records in Fourth Quarter and Full Year 2025, with Revenue of $5.4 million and $14.2 million, Respectively Provides First Quarter 2026 Revenue Guidance of $5.0 to $5.2 million Representing Up to 77% Growth Compared to Prior Year Period Driven by Arps Acquisition Updates Full Year 2026 Revenue Guidance to $28 to $32 million and Full Year 2026 Adjusted EBITDA Guidance to $3.2-$3.8 million Recently Secured $7.5 million in Strategic Financing to Accelerate Manufacturing Expansion; Facility Framework Supports Over $200 million in Future Revenue Capacity LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today reported financial results for the fourth quarter and fiscal year ended December...

FREDERICK, Md., March 31, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the year ended December 31, 2025, and provided an update on strategic initiatives designed to drive long-term growth. 2025 Highlights:Recap of 2025: TOMI made meaningful strides across multiple strategic priorities. We continued to strengthen our government relationships, highlighted by our selection by NASA for a biosecurity operation for our reliability in mission-critical environments. Commercially, we announced several new customer wins across global CDMOs, leaders in eye health, and prestigious university research groups. In parallel, regulatory and...

DENVER, March 31, 2026 (GLOBE NEWSWIRE) — authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the Fourth Quarter and Fiscal Year ended December 31, 2025. Fourth Quarter 2025 vs. Fourth Quarter 2024 Financial SummaryTotal revenue for the quarter was $0.4 million, compared to $0.2 million a year ago. Operating expenses were $4.5 million, compared to $4.9 million a year ago. Net loss was $4.0 million, or $0.28 per share, compared to a loss of $4.6 million, or $0.42 per share a year ago. Adjusted EBITDA Loss of $3.0 million (non-GAAP measure as defined below), compared with $4.1 million a year ago. Gross bARR (Booked Annual Recurring Revenue) of $0.1 million (non-GAAP measure as defined below), compared...

Full-Year 2025 revenue of $102.4 million, a 77.3% increase over the prior-year period  Company Continues to Drive Meaningful Cost Reductions Company Issues Full Year 2026 Financial Guidance Strategic Alternatives Review Advancing with Clear Path Forward Expected in Q2 WALTHAM, Mass., March 31, 2026 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “Nano”, or the “Company”), a leader in digital manufacturing solutions, today announced financial results for the fourth quarter and full year ended December 31, 2025. The consolidated results incorporate the financial position and performance of Markforged Holding Corporation (“Markforged”) from the acquisition date of April 25, 2025. Desktop Metal, Inc. (“Desktop Metal”) was acquired by the Company on April 2, 2025. The results of Desktop Metal from April 2, 2025...

Revenue of $9.7 million in Q4 2025, up 64% year-over-year; full year revenue of $21.2 million, up 201% year-over-year On a pro forma basis, combined company revenue of $34.0 million for full year 2025, compared to $13.7 million in 2024, an increase of 149% Delivered 65 vehicles in Q4 2025 and 112 vehicles for full year 2025, compared to 46 vehicles in full year 2024 Combined delivered trucks surpassed 20 million real-world miles across more than 1,100 deployed vehicles Targeting $20 million in annualized cost synergies from merger integration as the company exits 2026 Announced a 140 kWh battery configuration of W56 step van in response to customer demandDETROIT, March 31, 2026 (GLOBE NEWSWIRE) — Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse” or the “Company”), a North American OEM and provider of all-electric trucks, step...

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics sold its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205 million; Cyprium is also eligible to receive tiered royalties and up to approximately $128 million in aggregate sales milestones from Sentynl Therapeutics Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress remains eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on net sales of UNLOXCYT™ (cosibelimab-ipdl) MIAMI, March 31, 2026 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue,...

Fourth Quarter Product Revenues Grew 19.8% Year-over-Year and Net Loss Improved by $0.8 Million; Collection Activities on $78 Million Final Judgement Underway CORSICANA, Texas, March 31, 2026 (GLOBE NEWSWIRE) — Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today reported financial results for the fourth quarter and full year ended December 31, 2025. Key Fourth Quarter 2025 & Subsequent Operational HighlightsSuccessfully uplisted to the NYSE American in February 2026 with a concurrent public offering raising aggregate gross proceeds of approximately $16.6 million, including the partial exercise of the underwriters’ over-allotment option, significantly strengthening the Company’s balance...

Initiated a formal process to monetize assets  Implemented a restructuring plan to significantly reduce operating expenses and extend runwaySAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced its financial results for the full year and fourth quarter ended December 31, 2025 and provided business highlights. “As we evaluate strategic paths forward, our focus remains on supporting the advancement of the ongoing Phase 1 study of BA3182 in adenocarcinomas, while preserving capital, and ensuring we maintain the flexibility to pursue all potential value‑creating options,” said Jay M. Short, Ph.D., Chairman, Chief Executive Officer...

— Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval — ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to dateInitiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval. Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight. FemBloc permanent birth control system achieved certification under the Medical Device Single Audit Program...

Full year same store sales growth of 1%Decreased inventory by $29.1 million or 8.5%; reduced net debt by 6.1%Provides full year 2026 outlook WEST JORDAN, Utah, March 31, 2026 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen and fifty-two weeks ended January 31, 2026. “We are pleased with our improved fourth quarter finish and full-year performance, which exceeded our revised guidance following our third quarter of 2025, and reflects the meaningful progress we are making against our strategic initiatives,” said Paul Stone, Chief Executive Officer of Sportsman’s Warehouse. “In 2025, we returned to positive same store sales growth for the first time since 2020, while also strengthening our balance sheet, improving...